Price cap on cancer drugs increase to tackle shortage
India's drug regulator has increased the price caps for two essential platinum-based cancer drugs by 50% to address supply shortages. The move follows rising raw material costs and global supply chain disruptions.
Why it matters
Ensuring the availability of life-saving oncology medication is a critical public health priority.
The drug price regulator National Pharmaceutical Pricing Authority (NPPA) raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge in raw material costs triggered widespread shortages, according to a government notification seen by Reuters .
Reports on government policy and market factors neutrally.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in